BIOADAPTIVES, INC. Quarterly Debt-to-equity in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Bioadaptives, Inc. quarterly Debt-to-equity history and growth rate from Q2 2016 to Q3 2024.
  • Bioadaptives, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -104 %, a 3.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -104 +3.43 +3.2% Sep 30, 2024
Q2 2024 -109 -6.57 -6.44% Jun 30, 2024
Q1 2024 -109 -6.2 -6.05% Mar 31, 2024
Q4 2023 -108 -4.35 -4.19% Dec 31, 2023
Q3 2023 -107 -1.25 -1.18% Sep 30, 2023
Q2 2023 -102 +7.29 +6.67% Jun 30, 2023
Q1 2023 -102 +8.47 +7.64% Mar 31, 2023
Q4 2022 -104 +8.69 +7.73% Dec 31, 2022
Q3 2022 -106 +3.14 +2.88% Sep 30, 2022
Q2 2022 -109 -3.16 -2.98% Jun 30, 2022
Q1 2022 -111 -6.98 -6.72% Mar 31, 2022
Q4 2021 -112 -10.4 -10.2% Dec 31, 2021
Q3 2021 -109 -6.74 -6.58% Sep 30, 2021
Q2 2021 -106 -3.91 -3.82% Jun 30, 2021
Q1 2021 -104 -1.3 -1.27% Mar 31, 2021
Q4 2020 -102 Dec 31, 2020
Q3 2020 -102 Sep 30, 2020
Q2 2020 -102 Jun 30, 2020
Q1 2020 -103 Mar 31, 2020
Q3 2016 -173 Sep 30, 2016
Q2 2016 -150 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.